P02.07 Trial in progress: anti-PD1, capecitabine, and oxaliplatin for the first-line treatment of dMMR esophagogastric cancer (AuspiCiOus-dMMR): a proof-of-principle study (AuspiCiOus)

• HWM van Laarhoven,
• J Bos,
• N Haj Mohammad,
• S Derks

Affiliations

HWM van Laarhoven

13University of Amsterdam, Netherlands

J Bos

J Bos, P P F M Kuijer, M H W Frings-Dresen, Coronel Institute for Occupational and Environmental Health, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

N Haj Mohammad

4UMC Utrecht, Utrecht, Netherlands

S Derks

1Amsterdam UMC, Amsterdam, Netherlands